BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 26417314)

  • 1. Epigenetics in diagnosis, prognostic assessment and treatment of cancer: an update.
    Hatzimichael E; Lagos K; Sim VR; Briasoulis E; Crook T
    EXCLI J; 2014; 13():954-76. PubMed ID: 26417314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetically Active Drugs Inhibiting DNA Methylation and Histone Deacetylation.
    Chistiakov DA; Myasoedova VA; Orekhov AN; Bobryshev YV
    Curr Pharm Des; 2017; 23(8):1167-1174. PubMed ID: 27774908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetics and cancer, 2nd IARC meeting, Lyon, France, 6 and 7 December 2007.
    Lambert MP; Herceg Z
    Mol Oncol; 2008 Jun; 2(1):33-40. PubMed ID: 19383327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetics in cancer: targeting chromatin modifications.
    Ellis L; Atadja PW; Johnstone RW
    Mol Cancer Ther; 2009 Jun; 8(6):1409-20. PubMed ID: 19509247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential of epigenetic therapies in the management of solid tumors.
    Valdespino V; Valdespino PM
    Cancer Manag Res; 2015; 7():241-51. PubMed ID: 26346546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel epigenetic therapies in hematological malignancies: Current status and beyond.
    Gallipoli P; Huntly BJP
    Semin Cancer Biol; 2018 Aug; 51():198-210. PubMed ID: 28782607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitors of DNA Methylation and Histone Deacetylation as Epigenetically Active Drugs for Anticancer Therapy.
    Myasoedova VA; Sukhorukov V; Grechko AV; Zhang D; Romanenko E; Orekhov V; Orekhov AN
    Curr Pharm Des; 2019; 25(6):635-641. PubMed ID: 30950345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The epigenetics of breast cancer - Opportunities for diagnostics, risk stratification and therapy.
    Schröder R; Illert AL; Erbes T; Flotho C; Lübbert M; Duque-Afonso J
    Epigenetics; 2022 Jun; 17(6):612-624. PubMed ID: 34159881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetics as a therapeutic target in breast cancer.
    Connolly R; Stearns V
    J Mammary Gland Biol Neoplasia; 2012 Dec; 17(3-4):191-204. PubMed ID: 22836913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer epigenetics and the potential of epigenetic drugs for treating solid tumors.
    Liu Z; Gao Y; Li X
    Expert Rev Anticancer Ther; 2019 Feb; 19(2):139-149. PubMed ID: 30470148
    [No Abstract]   [Full Text] [Related]  

  • 11. Epigenetics: an emerging technology in the diagnosis and treatment of cancer.
    Stebbing J; Bower M; Syed N; Smith P; Yu V; Crook T
    Pharmacogenomics; 2006 Jul; 7(5):747-57. PubMed ID: 16886899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Histone Modifications and Their Therapeutic Targeting in Hematological Malignancies.
    Markouli M; Strepkos D; Piperi C
    Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The DNA methylation landscape of hematological malignancies: an update.
    Blecua P; Martinez-Verbo L; Esteller M
    Mol Oncol; 2020 Aug; 14(8):1616-1639. PubMed ID: 32526054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of epigenetics in kidney malignancies.
    la Rosa AH; Acker M; Swain S; Manoharan M
    Cent European J Urol; 2015; 68(2):157-64. PubMed ID: 26251734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer epigenetics: Moving forward.
    Nebbioso A; Tambaro FP; Dell'Aversana C; Altucci L
    PLoS Genet; 2018 Jun; 14(6):e1007362. PubMed ID: 29879107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights into novel emerging epigenetic drugs in myeloid malignancies.
    Chandhok NS; Prebet T
    Ther Adv Hematol; 2019; 10():2040620719866081. PubMed ID: 31431820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Status and Prospects of Epigenetics in the Treatment of Lymphoma.
    Liu J; Li JN; Wu H; Liu P
    Front Oncol; 2022; 12():874645. PubMed ID: 35463343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The epigenetics of prostate cancer diagnosis and prognosis: update on clinical applications.
    Blute ML; Damaschke NA; Jarrard DF
    Curr Opin Urol; 2015 Jan; 25(1):83-8. PubMed ID: 25405932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetics in bladder cancer.
    Enokida H; Nakagawa M
    Int J Clin Oncol; 2008 Aug; 13(4):298-307. PubMed ID: 18704629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer epigenetics in clinical practice.
    Davalos V; Esteller M
    CA Cancer J Clin; 2023; 73(4):376-424. PubMed ID: 36512337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.